[1]
Saif, M.W. et al. 2013. A Retrospective Study of Capecitabine/Temozolomide (CAPTEM) Regimen in the Treatment of Metastatic Pancreatic Neuroendocrine Tumors (pNETs) after Failing Previous Therapy. JOP. Journal of the Pancreas. 14, 5 (Sep. 2013), 498–501. DOI:https://doi.org/10.6092/1590-8577/1589.